Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis2018-01-17T17:06:28-04:00
New insights into the pathology of multiple sclerosis: towards a unified concept? New insights into the pathology of multiple sclerosis: towards a unified concept?2018-01-17T17:06:28-04:00
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage2018-01-17T17:06:28-04:00
Loss of Functional Suppression by CD4CD25 Regulatory T Cells in Patients with Multiple Sclerosis Loss of Functional Suppression by CD4CD25 Regulatory T Cells in Patients with Multiple Sclerosis2018-01-17T17:06:22-04:00
Experimental models of neuroprotection relevant to multiple sclerosis Experimental models of neuroprotection relevant to multiple sclerosis2018-01-17T17:06:15-04:00
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects2018-01-17T17:06:15-04:00
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event2018-01-17T17:06:09-04:00
The role of T helper cells in neuroprotection and regeneration The role of T helper cells in neuroprotection and regeneration2018-01-17T17:06:02-04:00
The Immunological Basis for Treatment of Multiple Sclerosis The Immunological Basis for Treatment of Multiple Sclerosis2018-01-17T17:06:02-04:00
Diagnosis and treatment of multiple sclerosis Diagnosis and treatment of multiple sclerosis2018-01-17T17:06:02-04:00
